BioNTech SE BNTX
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Terence Flynn | Morgan Stanley | 104.48 $ | 131 $ | 26.52 % | 10/10/2025 |
| Mohit Bansal | Wells Fargo | 111.07 $ | 150 $ | 38.93 % | 05/08/2025 |
| Terence Flynn | Morgan Stanley | 112.26 $ | 133 $ | 20.74 % | 10/07/2025 |
| Daina Graybosch | Leerink Partners | 113.1 $ | 112 $ | -1.10 % | 02/06/2025 |
| Asad Haider | Goldman Sachs | 98.45 $ | 110 $ | 11.55 % | 29/05/2025 |
| Robert Burns | H.C. Wainwright | 97.27 $ | 134 $ | 36.73 % | 14/05/2025 |
| Cory Kasimov | Evercore ISI | 80.8 $ | 125 $ | 44.20 % | 19/11/2024 |
| Daina Graybosch | Leerink Partners | 80.8 $ | 121 $ | 40.20 % | 13/11/2024 |
| Chris Shibutani | Goldman Sachs | 110.66 $ | 137 $ | 26.34 % | 08/11/2024 |
| Etzer Darout | BMO Capital | 108.97 $ | 126 $ | 17.03 % | 04/11/2024 |
| Terence Flynn | Morgan Stanley | 113.05 $ | 145 $ | 31.95 % | 23/09/2024 |
| Akash Tewari | Jefferies | 123.97 $ | 150 $ | 26.03 % | 17/09/2024 |
| Tazeen Ahmad | Bank of America Securities | 123.4 $ | 150 $ | 26.60 % | 16/09/2024 |
| Akash Tewari | Jefferies | 105 $ | 96 $ | -9.00 % | 13/09/2024 |
| Emmanuel Papadakis | Deutsche Bank | 79.5 $ | 95 $ | 15.50 % | 06/08/2024 |
| Terence Flynn | Morgan Stanley | 78.36 $ | 93 $ | 14.64 % | 05/08/2024 |
| Yifeng Liu | HSBC | 82.01 $ | 101 $ | 18.99 % | 02/08/2024 |
| Raghuram Selvaraju | H.C. Wainwright | 82.52 $ | 113 $ | 30.48 % | 26/06/2024 |
| Cory Kasimov | Evercore ISI | 92.72 $ | 100 $ | 7.28 % | 13/05/2024 |
| Etzer Darout | BMO Capital | 91.53 $ | 122 $ | 30.47 % | 07/05/2024 |
| Yifeng Liu | HSBC | 91.83 $ | 90 $ | -1.83 % | 22/03/2024 |
| William Maughan | Canaccord Genuity | 91.99 $ | 171 $ | 79.01 % | 21/03/2024 |
| Etzer Darout | BMO Capital | 91.99 $ | 123 $ | 31.01 % | 21/03/2024 |
| Chris Shibutani | Goldman Sachs | 91.99 $ | 91 $ | -0.99 % | 21/03/2024 |
| Mani Foroohar | Leerink Partners | 169.47 $ | 81 $ | -88.47 % | 02/12/2022 |
| Andrew Ang | UBS | 159.8 $ | 168 $ | 8.20 % | 17/05/2022 |
| Matthew Harrison | Morgan Stanley | 140.32 $ | 195 $ | 54.68 % | 10/05/2022 |
| Robert Burns | H.C. Wainwright | 175.29 $ | 298 $ | 122.71 % | 16/04/2022 |
| Arlinda Lee | Canaccord Genuity | 170.26 $ | 300 $ | 129.74 % | 10/04/2022 |
| Eliana Merle | UBS | 147.5 $ | 170 $ | 22.50 % | 21/01/2022 |
| Suzanne van Voorthuizen | Kempen & Co | 259.7 $ | 350 $ | 90.30 % | 22/12/2021 |
| Daina Graybosch | Leerink Partners | 284.21 $ | 253 $ | -31.21 % | 09/12/2021 |
| Olga Smolentseva | Bryan Garnier & Co Ltd | 248.9 $ | 359 $ | 110.10 % | 04/10/2021 |